ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselMabTree Biologics AG
MabTree Biologics AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

MabTree Biologics AG researches and develops therapeutic antibodies and antibody-drug conjugates. Its product development focuses on cancer and autoimmune diseases.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

MabTree Biologics AG

✓ Offered5
Development of therapeutic antibodies
Development of novel, targeted human monoclonal antibodies for the treatment of cancer and autoimmune diseases.
Development of antibody-drug conjugates
Development and commercialization of differentiated antibody-drug conjugates for cancer and autoimmune therapies.
Partnerships for antibody therapies
Partnerships to access third-party technologies and antibody-based products for the development of First-in-class or Best-in-class therapies.
Research and product discovery in biologics
Research, product discovery, and platform technologies for new therapeutic antibodies against challenging target structures and disease biology.
Pipeline development for immunotherapies
Development of a pipeline of drug candidates for immunological diseases and immuno-oncology based on fully human, affinity-matured antibodies.
Trust & reputation

ranQ Trust Score of MabTree Biologics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

MabTree Biologics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
MabTree Biologics AG scores 78.6 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
MabTree Biologics AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
MabTree Biologics AG scores 4.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.4.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

MabTree Biologics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once MabTree Biologics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

MabTree Biologics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank MabTree Biologics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of MabTree Biologics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60c
4057 Basel

At a glance

Legal form
Corporation
UID
CHE-211.971.736
Founded
2019 · 7 years
Last commercial register change
February 23, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    MR
    Monte Rosa Therapeutics AG
    Basel
    NA
    NBE-Therapeutics AG
    Basel
    SB
    SOTIO Biotech AG
    Basel
    YA
    Ymmunobio AG
    Riehen
    LT
    LifeMine Therapeutics (Switzerland) GmbH
    Basel
    GB
    Granite Bio AG
    Basel
    AT
    ABBA Therapeutics AG
    Basel
    FI
    FatiAbGen International GmbH
    Basel